NEW APPROACHES TO ASSESSING DRUG SAFETY WILL HELP REDUCE DEVELOPMENT TIME AND COSTS

Dramatic improvements in drug development efficiency -- getting more new medicines to market and reducing the time it takes to get them there -- are possible, but require new approaches to assessing drug safety, according to a panel of industry leaders convened by the Tufts Center for the Study of Drug Development. Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=729824)